Harrow, Inc. (HROW) Description, Stock price, News & Info.

#ThinkSabio Latest News

Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery